BALERNA, Switzerland & LANGENFELD, Germany--(BUSINESS WIRE)--BioAlliance received DCP approval in the major 16 European countries of Setofilm®, a film strip formulation containing 4mg and 8mg Ondansetron, co-developed by APR, Labtec and MSRx and licensed for marketing to BioAlliance. It is the first prescription drug product ever approved in a dosage form based on film strip technology on a worldwide basis.
